Lungs & Airways

Patient input needed for Cochrane Airways updated review on asthma and drug treatments

Skills / interests: Consumer (public, patient, carer) input

Mepolizumab, reslizumab and benralizumab are new 'anti-IL-5' treatments that may help to reduce asthma symptoms.

The author team in this review considered whether taking the new drugs mepolizumab, reslizumab or benralizumab in addition to standard treatment (e.g. inhaled steroids and combination inhalers) are better than a placebo for people with asthma.

Ideal applicant

We would like any adults or children who have a diagnosis of asthma to give us their views on this Cochrane Review update.

Think you've got what it takes to get the job done for Emma?

Log in
to respond

Questions & comments